UBS Group’s Sensei Biotherapeutics SNSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4K | Buy |
2,140
+13
| +0.6% | +$112 | ﹤0.01% | 7189 |
|
|
2025
Q1 | $16.8K | Buy |
+2,127
| New | +$16.8K | ﹤0.01% | 7039 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 8616 |
|
|
2024
Q2 | – | Sell |
-7
| Closed | -$146 | – | 8731 |
|
|
2024
Q1 | $146 | Buy |
+7
| New | +$146 | ﹤0.01% | 7608 |
|
|
2023
Q3 | – | Sell |
-326
| Closed | -$7.42K | – | 8658 |
|
|
2023
Q2 | $7.42K | Buy |
326
+154
| +90% | +$3.51K | ﹤0.01% | 6216 |
|
|
2023
Q1 | $5.16K | Buy |
172
+117
| +213% | +$3.51K | ﹤0.01% | 6978 |
|
|
2022
Q4 | $1.64K | Sell |
55
-601
| -92% | -$17.9K | ﹤0.01% | 8626 |
|
|
2022
Q3 | $20K | Sell |
656
-17
| -3% | -$518 | ﹤0.01% | 6314 |
|
|
2022
Q2 | $31K | Sell |
673
-8
| -1% | -$368 | ﹤0.01% | 5340 |
|
|
2022
Q1 | $31K | Sell |
681
-439
| -39% | -$20K | ﹤0.01% | 5933 |
|
|
2021
Q4 | $130K | Buy |
1,120
+1,070
| +2,140% | +$124K | ﹤0.01% | 4995 |
|
|
2021
Q3 | $11K | Buy |
50
+15
| +43% | +$3.3K | ﹤0.01% | 6760 |
|
|
2021
Q2 | $7K | Sell |
35
-70
| -67% | -$14K | ﹤0.01% | 7245 |
|
|
2021
Q1 | $31K | Buy |
+105
| New | +$31K | ﹤0.01% | 5977 |
|